Erika Turkstra, MSc, PhD

Dr Turkstra is a Principal Consultant within Parexel Access Consulting, with over 15 years of experience in pricing and market access. She has managed and led market access consulting projects, including health technology assessment submissions, global evidence and value dossiers, value-based solutions of high-priced products, health economics and outcome research evidence generation plans, primary research (advisory boards, payer/clinical expert interviews).

She has a wealth of therapeutic experience including multiple sclerosis, respiratory diseases, oncology, haematology, gastrointestinal diseases, rare diseases and cardiovascular diseases. She also has been an issue panel member at a recent ISPOR Europe conference discussing subscription-based models and has had various oral and poster presentations at ISPOR and HTAi conferences.

Work experience

Prior to joining Parexel in 2017, Dr Turkstra was an associate professor in health technology assessment at Griffith University, Australia. She worked for over ten years at university-based health technology assessment teams for the evaluation of pharmaceutical submissions to the Pharmaceutical Benefits Advisory Committee (Australia). She was the programme manager of the health technology assessment team for over seven years. She is a co-author on one book chapter and eight journal publications in the area of health technology assessment, cost-effectiveness, systematic literature reviews and network-meta-analyses. She is also co-author on two ISPOR global health care systems road maps for Australia (Pharmaceuticals and Medical devices).

Education

Dr Turkstra holds a MSc in Medical biology from the University of Groningen and a PhD in Medicine (Nitric oxide and angiotensin II interaction on renal hemodynamics in normal and renovascular hypertensive rats) at the University of Utrecht.